Systematic Review
Copyright ©The Author(s) 2019.
World J Gastroenterol. Oct 21, 2019; 25(39): 6016-6024
Published online Oct 21, 2019. doi: 10.3748/wjg.v25.i39.6016
Figure 1
Figure 1 Flowchart for identifying eligible studies and study selection process.
Figure 2
Figure 2 Meta-analysis and subgroup analysis of morbidity in p-ALPPS vs ALPPS (Dindo-Clavien classification ≥ 3a). ALPPS: Associating liver partition and portal vein ligation for staged hepatectomy; p-ALPPS: Partial split of the liver parenchyma in associating liver partition and portal vein ligation for staged hepatectomy; CI: Confidence interval.
Figure 3
Figure 3 Meta-analysis and subgroup analysis of postoperative mortality in p-ALPPS vs ALPPS. ALPPS: Associating liver partition and portal vein ligation for staged hepatectomy; p-ALPPS: Partial split of the liver parenchyma in associating liver partition and portal vein ligation for staged hepatectomy; CI: Confidence interval.
Figure 4
Figure 4 Meta-analysis of p-ALPPS vs ALPPS, and comparison of FLR hypertrophy in none-cirrhosis group. FLR: Future liver remnant; ALPPS: Associating liver partition and portal vein ligation for staged hepatectomy; p-ALPPS: Partial split of the liver parenchyma in associating liver partition and portal vein ligation for staged hepatectomy; CI: Confidence interval.
Figure 5
Figure 5 Funnel plot of publication bias. OR: Odds ratio.